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Background: Disparities of Minor H antigens can induce graft 
rejection after MHC-matched transplantation. H60 has been 
characterized as a dominant antigen expressed on hema-
topoietic cells and considered to be an ideal model antigen 
for study on graft-versus-leukemia effect. Methods: Spleno-
cytes from C57BL/6 mice immunized with H60 congenic 
splenocytes were used for establishment of H60-specific 
CTL clones. Then the clones were characterized for pro-
liferation capacity and cytotoxicity after stimulation with 
H60. Clone #14, #15, and #23 were tested for the TCR 
binding avidity to H60-peptide/H-2K
b and analyzed for TCR 
sequences. Results: H60-specific CTL clones showed differ-
ent levels of proliferation capacity and cytotoxic activity to 
H60-stimulation. Clones #14, #15, and #23 showed high 
proliferation activity, high cytotoxicity, and low activities on 
both aspects, respectively, and have TCRs with different 
binding avidities to H60-peptide/H-2K
b with t1/2 values of 
4.87, 6.92, and 13.03 minutes, respectively. The TCR usages 
were Vα12D-3-01＋Jα11-01 and Vβ12-1-01＋Dβ1-01 
＋J2-7-01 for clone #14, Vα13D-1-02＋Jα34-02 and 
Vβ13-1-02＋Dβ2-01＋Jβ2-7-01 for clone #15, and 
Vα16D＋Jα45-01 and Vβ12-1-01＋Dβ1-01＋Jβ2-5-01 
for clone #23. Conclusion: The results will be useful for mod-
eling GVL and generation TCR transgenic mouse.
[Immune Network 2011;11(2):100-106]
INTRODUCTION
Allograft rejection is the major barrier for the success of solid 
tissue and stem cell transplantation. Major risk factor for the 
rejection  is  mismatch  at  MHC  locus  between  donor  and 
recipient. Allograft rejection, however, still occurs even after 
MHC-matched transplantation for incompatibility of minor his-
tocompatibility (H) antigens (1). Minor H antigens are peptide 
fragments derived from polymorphic proteins in association 
with MHC class I and II, able to induce CD4 and CD8 T cell 
responses (2). Considering the disparities at multiple minor 
H antigens upon the transplantation between MHC-matched 
but background-mismatched individuals, antigenic complexity 
could be enormous but, in reality, immune response focuses 
on a few dominant H antigens, exhibiting the phenomenon 
of  immunodominance  (3,4).  In  B6  anti-BALB.B  system,  a 
multiple  minor  H  antigen-mismatched  case,  immune  re-
sponses against a few dominant minor H antigens, H60, H28, 
H4, and H7, account for more than 85% of total CD8 T cells 
response and, among those dominant minor H antigens, H60 
is dominant over all other minor H antigens, with high fre-
quency of reactive CD8 T cells detected in blood during the 
B6  anti-BALB.B  response  (4).
    Not  only  for  the  dominancy  of  specific  CD8  T  cell  re-
s p o n s e ,  a l s o  f o r  i t s  h e m a t o p o i e t i c  c e l l - r e s t r i c t e d  e x p r e s s i o n ,  
H60 has been paid attention to and considered as an ideal 
model antigen for study on graft-versus-leukemia (GVL) effect 
(5).  T  cells  originated  from  hematopoietic  stem  cell  donor 
recognize and react against allo-minor H antigens expressed 
in leukemic tumor cells residing in the recipient of the stem 
c e l l s ,  e x e r t i n g  G V L  e f f e c t ,  i n  a d dition  to  their  capability  to 
induce graft-versus-host disease (GVHD) through the allo-re-
action against minor H antigens expressed on tissues (6-9). Clonal Characterization of H60-specific CTL Clones
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In this respect, CD8 T cells reactive to dominant and hema-
topoietic  cell-restricted  H60  would  be  exploited  for  tumor 
therapy and, for this, H60-specific CD8 T cell clones would 
be  useful  tool  for  modeling  GVL  effect  in  mouse.
    The H60-specific response is initiated by the recognition of 
8-a.a. peptide (LTFNYRNL) in the context of H-2K
b by TCR 
expressed on CD8 T cells (5). H60 peptide/MHC complexes 
induce specific CD8 T cell response in CD4 help dependent 
manner.  The  help  is  mediated  via  CD40-CD40L  interaction 
and is required not only for the induction of primary response 
but also for the memory cell expansion (10). The dominance 
of H60-specific response has been ascribed to high precursor 
frequency of the reactive CD8 T cells and the frequency was 
estimated to be one out of 10,000∼20,000 cells (11). Spectra-
t y p i n g  a n d  s e q u e n c i n g  o f  t h e  C D 8  T  c e l l s  p a r t i c i p a t i n g  i n  
H60-specific  responses  revealed  the  involvement  of  T  cells 
with wide variety of TCRs (12). Based upon these results, we 
decided to establish CD8 T cell clones reactive to H60 and 
identify the  TCR  sequences  of  the clones,  which would  be 
basis  for  modeling  of  GVL  and  generating  TCR  transgenic 
mouse, a useful tool for detailed analysis on the mechanism 
of the GVL effects. In order to do this, we established and 
characterized H60-specific CTL clones. And the TCR usages 
of  those  were  identified.
MATERIALS AND METHODS
Mice and immunization
C57BL/6 (B6) mouse was purchased from The Jackson labo-
ratory (Bar Harbor, ME, USA). H60 congenic mouse (B6.C- 
H60
c/DCR) was a kind gift from Dr. Roopenian (The Jackson 
Laboratory).  The  mice  were  bred  and  kept  under  specific 
pathogen  free  (SPF)  condition  at  the  center  for  animal  re-
source development of Seoul National University College of 
Medicine. To induce H60-specific CD8 T cell response in the 
B6 mice, splenocytes from male H60 congenic mice were in-
jected into female B6 mice via intraperitoneal route (2×10
7 
cells/mouse).
Antibodies and flow cytometry
Peripheral  blood  lymphocytes  and  splenocytes  from  immu-
n i z e d  m i c e ,  M L C  c e l l s ,  C T L  l i n e s ,  o r  C T L  c l o n e s  w e r e  i n -
cubated at 4
oC for 30 min in staining buffer (1×PBS contain-
ing 0.1% bovine serum albumin and 0.1% sodium azide) con-
taining  PE-labeled  H60-tetramer  and  FITC-labeled  CD11a 
(M17/4; eBioscience,  San Diego, CA) and APC-labeled CD8 
(53-6.7; eBioscience) antibodies. The stained cells were ana-
lyzed using a FACSCalibur equipped with CellQuest software 
(BD  Pharmingen,  San  Diego,  CA).
Generation of CTL clones
H60-specific CTL lines were established through mixed lym-
phocyte culture (MLC) of splenocytes obtained from the im-
munized B6 mice with those from H60 congenic mouse after 
irradiation (2,000 cGy) and regular re-stimulation with irradi-
ated  H60  congenic  splenocytes  afterward  in  DMEM  media 
supplemented with 5% FBS and IL-2 (50 U/ml). Limiting dilu-
tion was performed with the H60-specific CTL lines at the 5
th 
passage to obtain the H60-specific CTL clones. Then the es-
tablished  clones  were  maintained  through  regular  re-stim-
ulation  with  irradiated  H60  congenic  cells.
Proliferation assay of H60-specific CTL clones
CTL clones (5×10
4 cells) were cultured with irradiated H60 
congenic splencoytes (5×10
5 cells) in the presence of 5 U/ml 
and 20 U/ml of IL-2. After 48 hr, the co-culture was added 
with 
3H and further incubated for 18 hr. Then, the cells were 
harvested  and  the  incorporation  of 
3H  was  measured.
Cell-mediated lysis assay
The standard 
51Cr release assay was performed as described 
previously  (4).  In  brief, 
51Cr-labeled  T2-K
b  cells  were  in-
cubated  with  1μM  concentration  of  synthetic  peptides 
(LTFNYRNL for H60 and RGYVYQGL for VSV) for 30 min at 
37
oC for peptide loading onto the target cells and then co-in-
cubated at 37
oC with CTL clones (effectors) at E：T cell ratios 
of 2：1 and 10：1. Lysis of target cells was measured as spe-
cific lysis based on the levels of 
51Cr released by H60-loaded 
target  cells  relative  to  those  by  VSV-loaded  target  cells.
Inverse RT-PCR and identification of TCR usage of 
H60-specific clones
Total RNA was isolated from H60-speicific CTL clones and 2
μg were used for 1
st strand synthesis of cDNAs correspond-
ing to TCR alpha chain using a primer 5’-CTGGTTGCTCCAG-
GCAATGGCCCCATT-3’ ( T C R αR),  and  beta  chains  using  a 
primer 5’-AGGATTGTGCCAGAAGGTAGCAGAGAC-3’ (TCRβR). 
Second strand synthesis was done with E. coli DNA polymer-
ase  (Koschem,  Daejon,  Korea)  and  E.  Coli RN As e H  (K o s-
chem). For circularization, the ds cDNAs were incubated with 
T4 DNA ligase at 16
oC for overnight. The ligation mixtures 
were used for PCR amplification using the Cα-specific pri-Clonal Characterization of H60-specific CTL Clones
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Figure 1. Establishment and characterization of H60-specific CTL clones. (A) Female C57Bl/6 (B6) mice were immunized with splenocytes from
male H60 congenic mice, and, then, peripheral blood lymphocytes (PBLs) from the immunized mice were examined to see whether H60-specific
response was induced by staining with H60 tetramer and subsequent flow cytometry on day 10 post-immunization (left). On day 14, splenocytes
from the immunized mice were cultured with irradiated splenocytes from H60 congenic mouse and the mixed lymphocyte culture (MLC) was
re-stimulated regularly on weekly basis to generate H60-specific CTL line (right). H60-specific CTL clones were derived from the CTL line on 
passage 5. (B) Proliferation assay of the H60-specific CTL clones. Established H60-specific CTL clones were examined for their proliferation capacity
in reaction to the stimulation with H60 congenic cells in the presence of IL-2 at the concentrations of 5 U/ml (left) and 20 U/ml (right). 
3H
was added to the culture on 48 hr later and, after further induction for 18 hr, cells were harvested and 
3H-incorporation was measured. The
assay was performed in triplicates and the data represent three independent experiments.
mers, TCRAinvF (5’-TCTGGAACGTTCATCACTGACAAA ACT-3’) 
and  TCRAinvR  (5’-GGTGCT  GTCCTGAGACCGAGGATC-3’), 
and Cβ-specific primers TCRBinvF (5’-TACAAGGAGAGCAA-
TTATAGCTACTGC-3’) and TCRBinvR (5’-GCTTTTGATGGCT-
CAAACAAGGAGAC-3’).  35  cycles  at  an  annealing  temper-
ature of 60
oC were performed. Products of the inverse PCR 
were then cloned to pGEM-T vector and subsequently sub-
jected to sequence analysis. The TCR usages were identified 
according  to  the  IMGT  database.
Determination of relative avidity
CTL clones were labeled with 50μg/ml of PE-labeled H60- 
tetramer, incubated at 4
oC for 1 hr in FACs buffer and, then, 
washed extensively. Following this initial tetramer binding, an 
aliquot of 10
5 cells was chased in FACs buffer with incubation 
at 37
oC for indicated times. The clones were also stained with 
FITC-labeled  anti-TCRβ antibody  to  monitor  TCR  levels. 
Cells  were  analyzed  by  flow  cytometry.  Mean  fluorescence 
intensity (MFI) values of binding of tetramer and anti-TCRβ 
antibody  were  plotted.  The  t1/2  of  TCR-peptide/MHC  inter-
action  was  calculated  from  specific  mean  fluorescence  in-
tensity  using  nonlinear  regression  analysis  fitted  to  classical 
Michaelis-Menten  Kinetics  (Prism  version  5,  GraphPad,  San 
Diego,  CA).
RESULTS AND DISCUSSION
Generation of H60 specific CTL clones
Female  B6  mice  were  immunized  with  male  H60  congenic 
splenocytes and, on day 14 post-immunization, mixed leuko-
cyte culture (MLC) was set up with irradiated H60 congenic 
splenocytes. Through five rounds of re-stimulation of the MLC 
cells with irradiated H60 congenic splenocytes, H60-specific 
CTL line was established (Fig. 1A). While the frequency of Clonal Characterization of H60-specific CTL Clones
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Figure 2. Cytotoxicity of H60-specific CTL clones. CTL clones were 
incubated with 
51Cr-labeled T2-K
b cells after loading with H60 or VSV
peptide at the E：T ratios of 2：1 and 10：1. 
51Cr released into 
culture supernatant was measured and specific cytotoxicity was 
calculated in relation to the 
51Cr released in the VSV-peptide-included
wells. The assay was performed in triplicates and the mean values 
were plotted. The data represent three independent experiments.
H60-specific  CD8  T  cells  was  in  ranges  of  5∼10% of  CD8 
T cells in blood of the immunized B6 mice at the peak of 
response,  99%  of  the  established  CTL  line  was  positive  for 
H60-tetramer as shown by flow cytometry analysis (Fig. 1A). 
With  this  CTL  line  at  the  5
th p a s s a g e ,  l i m i t i n g  d i l u t i o n  w a s 
performed  to  obtain  H60-specific  CTL  clones.  Then,  CTL 
clones, each of which was originated from a single cell via 
the limiting dilution, were maintained through re-stimulation 
w it h ir rad ia te d  H 6 0 c on g e ni c c el ls o n w ee k l y b asi s an d 2 4 
CTL  clones  reactive  to  H60  were  established.
CTL clones have different capacity of proliferation
Among the initial 24 CTL clones obtained, finally, nine CTL 
c l o n e s  ( # 1 ,  3 ,  7 ,  1 3 ,  1 4 ,  1 5 ,  1 6 ,  1 7 ,  a n d  2 3 )  w e r e  a b l e  t o 
be  maintained  beyond  the  passage  seven  and  subjected  to 
clonal characterization. First, each CTL clone was tested for 
proliferation capacity in response to stimulation with irradi-
ated H60 congenic cells. When 
3H-incorporation by the CTL 
clones during the stimulation was measured, clone # 14 and 
#17 proliferated relatively highly (Fig. 2), even when the con-
centration of supplemented IL-2 was limiting (5 U/ml). The 
o t h e r  c e l l s ,  c l o n e  # 1 ,  # 3 ,  # 7 ,  # 1 5 ,  a n d  # 2 3 ,  s h o w e d  r a t h e r  
minimal, but enough to be maintained for next passage, pro-
liferation  by  the  stimulation.  These  data  demonstrated  that 
even though they were all H60-specific, each clone showed 
a  different  level  of  proliferation  capacity  in  reaction  to  the 
H60-stimulation.
Different capacity of CTL activity of the H60-specific 
CTL clones
Next, we examined whether cytotoxic activity of the H60-spe-
cific CTL clones would be different. In order to do this, the 
nine CTL clones were subjected to cell mediated lysis (CML) 
assay by incubating with 
51Cr-labeled and H60-peptide loaded 
T-2K
b target cells at two different effector/target ratios of 2：1 
and 10：1. In overall, cytotoxicity of the nine CTL clones was 
higher at the E：T ratio of 10：1 than 2：1 and, among the 
clones, clone #15 was distinguished for its high CTL activity 
against H60-loaded T-2K
b cells. The clone #14, which showed 
the second highest proliferation activity in reaction to stim-
ulation  with  H60  congenic  cells  (Fig.  1B),  belonged  to  the 
group with low CTL activity. This result combined with that 
from  proliferation  assay  demonstrated  that  even  though  all 
the CTL clones were specific for H60, they possessed different 
levels  of  proliferation  capacity  and  cytotoxicity.
Different binding affinity of H60-specific CTL clones 
for peptide/MHC complexes
Then, we wondered whether CTL clones would show differ-
ent  levels  of  TCR  affinity  to  cognate  ligand,  H60-peptide/ 
H-2K
b complexes. To examine this, the affinity was empiri-
cally measured via determining t1/2 of H60-peptide/H-2K
b-TCR 
interactions. We selected CTL clone #14, #15, and #23 based 
upon the clonal characteristics, for high proliferation capacity 
(#14),  high  cytotoxicity  activit y  ( # 1 5 ) ,  a n d  l o w  a c t i v i t i e s  i n  
both aspects (#23), respectively. The CTL clones were stained 
with  saturating amount  (50μg/ml) of  H60-teramer for 1 hr 
and, after washing, the cells were incubated at 37
oC for in-
dicated time period and examined for falling-off the tetramers 
f r o m  t h e i r  T C R  b y  f l o w  c y t o m e t r y  a n a l y s i s ,  m e a s u r i n g  t h e  
mean fluorescence intensity. To see whether TCR expression 
itself was influenced, the cells were also stained with anti-TCRβ 
antibody before flow cytometry analysis. When the mean flu-
orescence intensity (MFI) values of H60-tetramer and anti-TCRβ 
antibody staining were plotted, we found that initial MFI val-Clonal Characterization of H60-specific CTL Clones
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Figure 3. Biochemical features of 
the interaction of H60-peptide/ 
H-2K
b-TCR of H60-specific CTL 
clones (A) CTL clones, #14, #15, 
and #23, were reacted with H60- 
tetramer-PE, washed extensively and
incubated 37
oC for 1 hr. The disso-
ciation of the tetramer from cells 
during the chase was monitored by 
flow cytometry. (B) Cells were also 
stained with anti-TCRβ  antibody 
post-chase to detect TCR levels of 
the cells. The MFI values from the 
flow cytometry (A and B) were 
plotted. (C) Relative MFIs were MFI 
values at indicated time points 
fractionated by MFI value detected 
at the beginning of the chase. And 
the t1/2 was obtained based on this 
dissociation curve. The data repre-
sent two independent experiments.
ues of tetramer staining were different among the three CTL 
clones (Fig. 3A). The initial MFI value was highest with clone 
#15 (82) and lowest with clone #23 (30) with #14 in the inter-
mediate (58), even though the TCR level on the cell surfaces 
were not significantly different in a range of 28∼33 MFI val-
ues (Fig. 3B). This demonstrated that the three CTL clones, 
#14,  #15,  and  #23,  bound  to  H60-tetramer  with  different 
avidities.  When  the  t1/2  of  H60-peptide/H-2K
b-TCR  inter-
actions  was  calculated  (Fig.  3C),  the  duration  of  the  inter-
action was shortest in clone #14 (4.87 minutes) and longest 
in clone #23 (13.93 minutes), demonstrating that even though 
the  TCR  of  clone  #23  has  very  low  initial  avidity  to  the 
H60-peptide/H-2K
b,  the  interaction  is  stable.  Moreover,  the 
results  demonstrate  that  TCR  of  clone  #14,  which  has  high 
proliferation  capacity,  has  modes t  i n i t i a l  b i n d i n g  a v i d i t y  t o  
H60-peptide/H-2K
b but the duration of the binding is short. 
In the case of clone #15, the TCR interaction with H60 pep-
tide/H-2K
b initiated with high avidity and the interaction was 
rather  stable  with  about  7  minutes  of  t1/2.  All  these  results 
showed that each clone has its own TCR binding avidity to 
the  specific  ligand  as  well  as  proliferation  and  cytotoxic 
capacities.
Identification of TCR sequences of the H60-specific 
CTL clones
Then we thought that such clonal differences in proliferation 
activity,  cytotoxicity,  and  TCR  binding  avidity  to  H60  pep-
tide/H-2K
b would reflect different TCR usages of the clones. 
To identify the sequences encoding the TCRs expressed by 
clone  #14,  #15,  and  #23,  inverse  PCR  was  performed  with 
t h e RN As  e x tr ac te d  fr om  e ac h  c lo ne  a nd  t h e PC R p ro du c ts 
were  cloned  to  pGEM-T  vector  and  analyzed  for  sequence 
(Fig. 4). The sequence analysis revealed that the three CTL 
clones had different usages of TCRα and TCRβ. TCR com-
plex of CTL clone #14 consists of Vα12D-3-01 and Jα11-01 
for TCRα chain and Vβ12-1-01, Dβ1-01, and Jβ2-7-01 for 
TCRβ chain. CTL clone #15 consists of Vα13D-1-02 and Jα
34-02,  and  Vβ13-1-02,  Dβ2-01,  and  Jβ2-7-01  for  TCRα 
and β chains, respectively. TCR α and β chains of Clone 
#23 consists of Vα16D and Jα45-01, and Vβ12-1-01, Dβ
1-01, and Jβ2-5-01, respectively. Based upon the sequence 
analysis data, we could suggest that the different TCR usages 
by  each  clone  would  have  been  reflected  to  differences  in 
the  clonal  characteristics.
  From an antigenic standpoint, H60 has been found to re-
cruit CD8 T cells with diverse TCRs into the specific response, 
after  primary  challenge  as  well  as  after  memory  expansion 
stimulation (12). The results from this study through a series 
of  clonal  characterization  showed  that  the  CD8  T  cells  re-
cruited  to  H60-specific  CD8  T  cells  responses  would  have 
each different capacity, in terms of proliferation, cycotoxicity, 
and  TCR  avidity  to  the  cognate  ligand  H60  peptide/H-2K
b. 
And  the  H60-specific  CTL  clones  and  TCR  information  ob-
tained  in  this  study  would  be  useful  for  understanding  the Clonal Characterization of H60-specific CTL Clones
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Figure 4. Sequence analysis of H60-
specific CTL clones. (A) Annotation 
of TCR usages of H60-specific CTL 
clones, #14, #15, and #23, and (B) 
sequences of the CDR3 regions 
were shown.
cellular  mechanism of graft rejections  and GVHD, and  also 
for  modeling  the  GVL  effect  under  MHC-matched  trans-
plantation  condition.
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